Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity

被引:397
作者
Drappa, J
Vaishnaw, AK
Sullivan, KE
Chu, JL
Elkon, KB
机构
[1] CORNELL UNIV,HOSP SPECIAL SURG,MED CTR,DIV RHEUMATOL,NEW YORK,NY 10021
[2] UNIV PENN,CHILDRENS HOSP PHILADELPHIA,DIV PEDIAT,PHILADELPHIA,PA 19104
关键词
D O I
10.1056/NEJM199611283352204
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The Canale-Smith syndrome is a childhood disorder characterized by lymphadenopathy and autoimmunity. The similarity between this syndrome and that in mice with the lymphoproliferation (lpr) phenotype or the generalized-lymphoproliferative-disease (gld) phenotype led us to investigate whether it too is caused by mutations of the Fas gene (lpr mice) or the Fas ligand (gld mice), which regulate apoptosis in lymphocytes. Methods We studied four patients with the syndrome and their families. T-lymphocyte phenotypes were analyzed, and the susceptibility of activated T cells to Fas-mediated apoptosis in vitro was determined. Mutations of Fas were sought by nucleotide-sequence analysis. Results Patients with the Canale-Smith syndrome had increased numbers of circulating double-negative T cells (>20 percent) and profoundly impaired apoptosis of activated T cells incubated with an anti-Fas antibody. Three novel Fas mutations were identified, all of which were heterozygous and predicted to impair signal transduction by Fas. Autoimmune manifestations of the disease, such as hemolytic anemia and thrombocytopenia, persisted into adolescence. Two patients followed into adulthood had intermittent lymphadenopathy, which diminished over time. Neoplasms developed in both, and one died of hepatocellular carcinoma at the age of 43. Conclusions Patients with the Canale-Smith syndrome have mutations in Fas - a fact that implicates this gene in the accumulation of lymphocytes and the autoimmunity characteristic of the syndrome. (C)1996, Massachusetts Medical Society.
引用
收藏
页码:1643 / 1649
页数:7
相关论文
共 46 条
  • [1] TARGETED MUTATION IN THE FAS GENE CAUSES HYPERPLASIA IN PERIPHERAL LYMPHOID ORGANS AND LIVER
    ADACHI, M
    SUEMATSU, S
    KONDO, T
    OGASAWARA, J
    TANAKA, T
    YOSHIDA, N
    NAGATA, S
    [J]. NATURE GENETICS, 1995, 11 (03) : 294 - 300
  • [2] FAS-MEDIATED CYTOTOXICITY BY FRESHLY ISOLATED NATURAL-KILLER-CELLS
    ARASE, H
    ARASE, N
    SAITO, T
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (03) : 1235 - 1238
  • [3] ASHANY D, 1992, CLIN EXP IMMUNOL, V88, P84
  • [4] TH1 CD4+ LYMPHOCYTES DELETE ACTIVATED MACROPHAGES THROUGH THE FAS/APO-1 ANTIGEN PATHWAY
    ASHANY, D
    SONG, X
    LACY, E
    NIKOLICZUGIC, J
    FRIEDMAN, SM
    ELKON, KB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (24) : 11225 - 11229
  • [5] STRUCTURE OF THE HUMAN APO-1 GENE
    BEHRMANN, I
    WALCZAK, H
    KRAMMER, PH
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (12) : 3057 - 3062
  • [6] CHRONIC LYMPHADENOPATHY SIMULATING MALIGNANT LYMPHOMA
    CANALE, VC
    SMITH, CH
    [J]. JOURNAL OF PEDIATRICS, 1967, 70 (06) : 891 - +
  • [7] FADD, A NOVEL DEATH DOMAIN-CONTAINING PROTEIN, INTERACTS WITH THE DEATH DOMAIN OF FAS AND INITIATES APOPTOSIS
    CHINNAIYAN, AM
    OROURKE, K
    TEWARI, M
    DIXIT, VM
    [J]. CELL, 1995, 81 (04) : 505 - 512
  • [8] THE DEFECT IN FAS MESSENGER-RNA EXPRESSION IN MRL LPR MICE IS ASSOCIATED WITH INSERTION OF THE RETROTRANSPOSON, ETN
    CHU, JL
    DRAPPA, J
    PARNASSA, A
    ELKON, KB
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (02) : 723 - 730
  • [9] LPR AND GLD - SINGLE GENE MODELS OF SYSTEMIC AUTOIMMUNITY AND LYMPHOPROLIFERATIVE DISEASE
    COHEN, PL
    EISENBERG, RA
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1991, 9 : 243 - 269
  • [10] DHEIN J, 1992, J IMMUNOL, V149, P3166